XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses    
General and administrative $ 3,146 $ 2,694
Research and development 10,446 8,684
Total operating expenses 13,592 11,378
Operating loss (13,592) (11,378)
Other income (expense)    
Grant income 12
Research and development incentive income 412 592
Interest income, net 1,394 2,008
Foreign exchange gain (loss) (337) 156
Total other income, net 1,481 2,756
Net loss and comprehensive loss $ (12,111) $ (8,622)
Net Loss per share    
Net Loss per share, Basic $ (0.14) $ (0.11)
Net Loss per share, Diluted $ (0.14) $ (0.11)
Weighted average number of shares outstanding    
Weighted average number of shares outstanding, Basic 84,805,974 82,077,815
Weighted average number of shares outstanding, Diluted 84,805,974 82,077,815